Adagio Medical Holdings revenue was $523.00k for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down 100% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADGM annual revenue was $269.0k, with -10.3% growth year-over-year.
ADGM past revenue growth
How has ADGM's revenue growth performed historically?
Adagio Medical Holdings (NASDAQ: ADGM) reported Q1 2025 revenue of $0.00 up 100% year over year. In the same quarter last year, Adagio Medical Holdings's revenue was $26.00 thousand.
What was Adagio Medical Holdings's revenue in 2024?
Adagio Medical Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $269.00 thousand, a 10.33% decrease year over year.
How much does Adagio Medical Holdings make in a day?
Based on Adagio Medical Holdings annual revenue for the past five years, ADGM makes an average of $415.34 per day.
What was Adagio Medical Holdings's annual revenue growth in the past year?
As of Q2 2025, Adagio Medical Holdings's revenue has grown 96.62% year over year. This is 86.22 percentage points higher than the US Medical Devices industry revenue growth rate of 10.39%. Adagio Medical Holdings's revenue in the past year totaled $523.00 thousand.
How much does Adagio Medical Holdings make in a year?
Adagio Medical Holdings's revenue by year for the past five years is:
Adagio Medical Holdings's revenue for the twelve months ending Dec 31, 2024 was $269.00 thousand, a 10.33% decrease year over year.
Adagio Medical Holdings's annual revenue for Dec 31, 2023 was $300.00 thousand, a 58.73% increase from 2022.
Adagio Medical Holdings's annual revenue for 2022 was $189.00 thousand, a Infinity% increase from 2021.
Adagio Medical Holdings's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Adagio Medical Holdings's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.